Delivery Order SPE2D019D0004-SPE2D326F2060
- Not listed
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,493.70 to Baxter Healthcare Corporation for the supply of Sodium Chloride 3% Intravenous Solution in 500mL units. This firm fixed-price delivery order, issued on November 26, 2025, with an ultimate completion date of November 28, 2025, will be performed in Riverwoods, Illinois. The contract was awarded without a set-aside designation, reflecting Baxter's position as an established large-scale medical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $2,976.00 delivery order to Baxter Healthcare Corporation (UEI: RSKLEFCZ6127) on September 29, 2025, for the supply of Sodium Chloride 0.9% Solution in 500ML units. This firm fixed-price delivery order, with a completion date of September 30, 2025, represents a routine procurement of intravenous saline solution, a critical medical supply used across federal healthcare systems. The contract carries no small business set-aside...
- Baxter Healthcare Corporation was awarded a delivery order valued at $1,190.40 by the Defense-affiliated Medical Supply Chain on August 27, 2025, for the supply of Sodium Chloride 0.9% Solution in 500mL units. This is a firm fixed-price contract with performance in Riverwoods, Illinois, and an ultimate completion date of August 28, 2025. No small business set-aside was used for this award, consistent with Baxter's established position as a large federal medical supplier. Baxter Healthcare...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to Baxter Healthcare Corporation on September 17, 2025, for the supply of Sodium Chloride 0.9% Solution in 500mL units, with a ceiling value of $1,289.60 and an ultimate completion date of September 18, 2025. This is a firm fixed-price delivery order with no small business set-aside. The contract will be performed in Riverwoods, Illinois, and represents a continuation of Baxter's ongoing role as a critical supplier...
- Baxter Healthcare Corporation, a global medical products and services company headquartered in Deerfield, Illinois, has been awarded a delivery order valued at $9,820.80 by the Medical Supply Chain (a Defense-focused federal agency) for the supply of Sodium Chloride 0.9% Solution in 500ml units. The contract is a firm fixed-price delivery order with no small business set-aside, with performance to be executed in Riverwoods, Illinois, and an ultimate completion date of September 30, 2025. This...
- Baxter Healthcare Corporation, a global medical products and services company headquartered in Deerfield, Illinois, has been awarded a Purchase Order for intravenous injection supplies with a ceiling value of $1,576.53. The contract, awarded on July 22, 2025, is firm fixed price with an ultimate completion date of August 1, 2025, and will be performed in Riverwoods, Illinois. This award was made by the Medical Supply Chain, a defense-focused federal agency, and carries no small business...
- Baxter Healthcare Corporation, headquartered in Deerfield, Illinois, has been awarded a firm fixed-price purchase order by the Medical Supply Chain (Defense) for sodium chloride injection supplies. The award, issued on October 27, 2025, carries a ceiling value of $7,725.48 with an ultimate completion date of November 17, 2025. The contract is not set-aside for small businesses, and performance will take place in Riverwoods, Illinois. This purchase order represents a continuation of Baxter's...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to Baxter Healthcare Corporation on September 17, 2025, for the supply of Sodium Chloride 0.9% Solution in 500ml units, with a ceiling value of $1,388.80 and an ultimate completion date of September 18, 2025. This firm fixed-price delivery order is to be performed at Baxter's location in Riverwoods, Illinois. The award carries no small business set-aside designation, reflecting Baxter's established position as a...
- Baxter Healthcare Corporation, headquartered in Deerfield, Illinois, was awarded a delivery order valued at $4,960.00 by the Medical Supply Chain, a defense-focused federal agency, for the supply of Sodium Chloride 0.9% Solution in 500mL units. The contract is priced on a firm fixed-price basis with no small business set-aside and performance scheduled for completion by May 23, 2025. Baxter Healthcare will fulfill this order from its Riverwoods, Illinois facility. As a large, established medical...
- The U.S. Defense Medical Supply Chain awarded a delivery order to Baxter Healthcare Corporation on July 24, 2025, for the supply of Sodium Chloride 0.9% Solution in 500ml units, with a ceiling value of $1,984.00 and an ultimate completion date of July 29, 2025. This firm fixed-price delivery order does not utilize a small business set-aside and will be performed at Baxter's facility in Riverwoods, Illinois. Baxter Healthcare Corporation, a global medical products and services company...
- SPE2D019D0004Indefinite Delivery Contract
- SPE2D019D0004-SPE2D326F2060Delivery Order
The U.S. Defense Department's Medical Supply Chain awarded a $1,190.40 delivery order to Baxter Healthcare Corporation (UEI: RSKLEFCZ6127) on December 4, 2025, for the supply of 500 milliliter containers of 0.9% sodium chloride intravenous solution with vented low flow administration sets. The contract is structured as a firm fixed price delivery order with no small business set-aside and is scheduled for completion by December 5, 2025. The supplies will be delivered to Riverwoods, Illinois, reflecting Baxter's continued role as a critical supplier of intravenous fluids and related medical products to federal healthcare agencies. Baxter Healthcare Corporation, a globally recognized medical devices and pharmaceuticals company headquartered in Deerfield, Illinois, has established itself as a key federal contractor through its extensive portfolio of medical supply contracts with agencies including the Department of Veterans Affairs, Indian Health Service, and Defense Logistics Agency. The company holds significant indefinite delivery vehicles with these agencies, including a $63 million VA infusion pump contract extending through August 2030 and a $3 million Indian Health Service blanket purchase agreement for intravenous solutions through October 2028. As a large, established parent corporate entity, Baxter competes for federal contracts without set-aside restrictions and maintains strategic subcontracting relationships to expand its service capabilities across federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/3/25 |